Interacting Drugs |
Carbidopa-levodopa-entacapone vs Methylphenidate |
Security Level |
 |
Mechanism |
Methylphenidate: May enhance the adverse/toxic effect of Anti-Parkinson's Agents (Dopamine Agonist). |
Management |
Monitor therapy |
Carbidopa-levodopa-entacapone vs Methylphenidate
Post Review about Carbidopa-levodopa-entacapone vs Methylphenidate Click here to cancel reply.
Other Interactions of Carbidopa-levodopa-entacapone
Other Interactions of Methylphenidate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.